Analysts at Goldman Sachs initiated initiated coverage on
Xerox Corp (NYSE:
XRX) with a Neutral rating. The target price for Xerox is set to $10. Xerox shares closed at $10.55 on Monday.
JMP Securities initiated coverage on
Starwood Property Trust, Inc. (NYSE:
STWD) with a Outperform rating. The target price for Starwood Property Trust is set to $24. Starwood Property Trust shares closed at $20.33 on Monday.
Analysts at National Bank Financial initiated coverage on
Brookfield Infrastructure Partners L.P. (NYSE:
BIP) with a Outperform rating. The target price for Brookfield Infrastructure Partners is set to $50. Brookfield Infrastructure Partners shares closed at $41.54 on Monday.
Roth Capital initiated coverage on
BG Staffing Inc (NYSE:
BGSF) with a Buy rating. The target price for BG Staffing is set to $18. BG Staffing shares closed at $13.86 on Monday.
Analysts at UBS initiated coverage of
Questar Corporation (NYSE:
STR) with a Neutral rating. The target price for Questar is set to $19. Questar shares closed at $18.95 on Monday.
RBC Capital initiated coverage of
Sibanye Gold Ltd (ADR) (NYSE:
SBGL) with a Sector Perform rating. Sibanye Gold shares closed at $5.27 on Monday.
Susquehanna initiated coverage on
Avago Technologies Ltd (NASDAQ:
AVGO) with a Positive rating. The target price for Avago Technologies is set to $160. Avago Technologies shares closed at $130.45 on Monday.
Analysts at Stifel Nicolaus initiated coverage on
Vertex Pharmaceuticals Incorporated (NASDAQ:
VRTX) with a Buy rating. The target price for Vertex Pharmaceuticals is set to $125. Vertex Pharmaceuticals shares closed at $129.36 on Monday.
Analysts at Oppenheimer initiated coverage on
Leucadia National Corp. (NYSE:
LUK) with a Outperform rating. The target price for Leucadia National is set to $27. Leucadia National shares closed at $17.68 on Monday.
Analysts at Goldman Sachs initiated coverage on
CDW Corp (NASDAQ:
CDW) with a Buy rating. The target price for CDW is set to $52. CDW shares closed at $43.17 on Monday.
Market News and Data brought to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
